MedPath

Effect of oral progesterone(dydrogestron) on incidence of glucose intolerance in pregnant females with threatened abortio

Not Applicable
Conditions
Gestational Diabetes.
high-risk pregnancy
Registration Number
IRCT2015020217035N2
Lead Sponsor
Vice Chancellor Of Research, Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

singleton pregnancy, the absence of any systemic disease, age less than 30 years, BMI less than 25, no history of stillbirth, having a family history of diabetes
Exclusion criteria: smoking, history of diabetes, gestational diabetes and other systemic diseases, any fetal abnormalities on ultrasound, multiple pregnancy, previous macrosomia

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
FBS. Timepoint: At Gestational age 14 weeks. Method of measurement: Gelocometer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath